EE488 Budget Impact Analysis of Oral Treatment With Nirmaltrevir+Ritonavir for COVID-19 in Argentina

to estimate the budget impact (BI) of the oral treatment, nirmaltrevir+ritonavir, for mild-to-moderate coronavirus disease in adults who are at risk of progression to severe COVID-19 for the whole Argentinean health system.

Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: L. Rey-Ares, M.F. Viozzi, C. Vega, J. Elgart, M.L. Glancszpigel Source Type: research